TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TGTX TG Therapeutics Inc.

盘前交易 05-21 06:13:13 EDT

16.48

+0.00

0.00%

盘前16.48

+0.000.00%

05:39 EDT

最高16.65	最低16.23	成交量301.60万
今开16.62	昨收16.48	日振幅2.57%
总市值25.47亿	流通市值23.90亿	总股本1.55亿
成交额4,947万	换手率2.08%	流通股本1.45亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"TGTX","market":"US","secType":"STK","nameCN":"TG Therapeutics Inc.","latestPrice":16.48,"timestamp":1716235200000,"preClose":16.48,"halted":0,"volume":3016028,"hourTrading":{"tag":"盘前","latestPrice":16.48,"preClose":16.48,"latestTime":"05:39 EDT","volume":200,"amount":3299.5002,"timestamp":1716284396961},"delay":0,"floatShares":145000000,"shares":154542945,"eps":0.279303,"marketStatus":"盘前交易","marketStatusCode":1,"change":0,"latestTime":"05-21 06:13:13 EDT","open":16.62,"high":16.649,"low":16.225,"amount":49474305.026259996,"amplitude":0.025728,"askPrice":18.39,"askSize":100,"bidPrice":16.48,"bidSize":97,"shortable":3,"etf":0,"ttmEps":0.279303,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716298200000},"adr":0,"listingDate":1128657600000,"adjPreClose":16.48,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":16.48,"preClose":16.48,"latestTime":"05:39 EDT","volume":200,"amount":3299.5002,"timestamp":1716284396961},"postHourTrading":{"tag":"盘后","latestPrice":16.4,"preClose":16.48,"latestTime":"19:54 EDT","volume":912198,"amount":15032688.23,"timestamp":1716249265133},"volumeRatio":0.8983600255894092},"requestUrl":"/m/hq/s/TGTX/wiki","defaultTab":"wiki","newsList":[{"id":"2435717383","title":"Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.17%报17.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435717383","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435717383?lang=zh_cn&edition=full","pubTime":"2024-05-13 23:01","pubTimestamp":1715612490,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日23时01分，Tg Therapeutics, Inc.股票出现波动，股价急速拉升5.17%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513230131861ecd9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240513230131861ecd9c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432281935","title":"HC Wainwright & Co.：维持TG Therapeutics(TGTX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至49.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432281935","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2432281935?lang=zh_cn&edition=full","pubTime":"2024-05-03 01:35","pubTimestamp":1714671304,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持TG Therapeutics(TGTX.US)评级，由买入调整至买入评级, 目标价由45.00美元调整至49.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030135058b6dd0ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405030135058b6dd0ac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428518674","title":"Tg Therapeutics, Inc.盘中异动 早盘急速拉升5.14%报14.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428518674","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428518674?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:38","pubTimestamp":1713451111,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日22时38分，Tg Therapeutics, Inc.股票出现波动，股价急速上涨5.14%。截至发稿，该股报14.53美元/股，成交量82.0128万股，换手率0.53%，振幅4.49%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的，商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的获得、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041822383187e81c1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041822383187e81c1d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416909593","title":"Tg Therapeutics, Inc.2023财年实现净利润12.67百万美元，同比增加106.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416909593","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416909593?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:23","pubTimestamp":1709483023,"startTime":"0","endTime":"0","summary":"12月31日，Tg Therapeutics, Inc.公布财报，公告显示公司2023财年净利润为12.67百万美元，同比增加106.40%；其中营业收入为2.34亿美元，同比增加8287.10%，每股基本收益为0.09美元。机构评级：截至2023年12月31日，当前有7家机构对Tg Therapeutics, Inc.目标价做出预测，其中目标均价为28.29美元，其中最低目标价为7.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400235487e0e48c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400235487e0e48c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416551642","title":"Tg Therapeutics, Inc.盘中异动 早盘股价大涨5.11%报18.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416551642","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416551642?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:48","pubTimestamp":1709304523,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时48分，Tg Therapeutics, Inc.股票出现异动，股价快速上涨5.11%。截至发稿，该股报18.10美元/股，成交量63.4059万股，换手率0.42%，振幅3.83%。Tg Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.12%。Tg Therapeutics, Inc.公司简介：TG Therapeutics Inc 是一家完全整合的商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122484379165ed8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030122484379165ed8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2415309490","title":"BUZZ-TG Therapeutics 第四季度营收超出预期，业绩大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2415309490","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2415309490?lang=zh_cn&edition=full","pubTime":"2024-02-29 02:51","pubTimestamp":1709146268,"startTime":"0","endTime":"0","summary":"    2月28日 - ** TG Therapeutics   股价上涨26%至17.53美元 ** TGTX第四季度总营收为4397万美元，分析师平均预期为4006万美元 - 伦敦证券交易所数据 ** 该公司维持其多发性硬化症 药物 Briumvi 2024 年的销售前景为 2.2 亿至 2.6 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2414788736","title":"TG Therapeutics Inc   预计每股亏损10美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2414788736","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2414788736?lang=zh_cn&edition=full","pubTime":"2024-02-26 21:51","pubTimestamp":1708955472,"startTime":"0","endTime":"0","summary":"   * TG Therapeutics Inc    预计将在2月28日公布截至2023年12月31日的季度收入报告。* 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于北卡罗来纳州莫里斯维尔的公司的营收预计将从一年前的8万美元增长49,979.1%，达到4,006.3万美元。* LSEG 的分析师平均预计 TG Therapeutics Inc 每股亏损 10 美分。* 华尔街对 TG Therapeutics Inc 的 12 个月目标价中位数为 39.00 美元，高于其上次收盘价 13.32 美元。2月26日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413766147","title":"TG Therapeutics Inc   预计每股亏损10美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413766147","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413766147?lang=zh_cn&edition=full","pubTime":"2024-02-23 21:47","pubTimestamp":1708696033,"startTime":"0","endTime":"0","summary":"   * TG Therapeutics Inc    预计将在2月26日公布截至2023年12月31日的业绩报告时显示季度收入增长(预计)    * 根据LSEG的数据，7位分析师的平均预期显示，这家总部位于北卡罗来纳州莫里斯维尔的公司的营收预计将从一年前的8万美元增长49,979.1%，达到4,006.3万美元。* LSEG 的分析师平均预计 TG Therapeutics Inc 每股亏损 10 美分。* 华尔街对 TG Therapeutics Inc 的 12 个月目标价中位数为 39.00 美元，高于其上次收盘价 13.44 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411368035","title":"Tg Therapeutics Inc盘中异动 早盘急速下跌5.20%报14.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411368035","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411368035?lang=zh_cn&edition=full","pubTime":"2024-02-13 22:31","pubTimestamp":1707834664,"startTime":"0","endTime":"0","summary":"北京时间2024年02月13日22时31分，Tg Therapeutics Inc股票出现异动，股价大幅下挫5.20%。截至发稿，该股报14.39美元/股，成交量4.8652万股，换手率0.03%，振幅0.78%。Tg Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Biodexa Pharmaceuticals Plc、Bioxcel Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大，Biodexa Pharmaceuticals Plc、Adial Pharmaceuticals Inc、Kintara Therapeutics Inc较为活跃，换手率分别为292.66%、79.83%、29.32%，振幅较大的相关个股有Indaptus Therapeutics Inc、Lisata Therapeutics Inc、Nuvalent Inc，振幅分别为7.09%、6.62%、6.19%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322310487e6fdec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021322310487e6fdec&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409443003","title":"Tg Therapeutics Inc盘中异动 大幅跳水5.15%报15.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2409443003","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409443003?lang=zh_cn&edition=full","pubTime":"2024-02-06 01:26","pubTimestamp":1707153979,"startTime":"0","endTime":"0","summary":"北京时间2024年02月06日01时26分，Tg Therapeutics Inc股票出现波动，股价大幅下挫5.15%。截至发稿，该股报15.61美元/股，成交量123.913万股，换手率0.82%，振幅4.92%。Tg Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，4D Molecular Therapeutics Inc、180 Life Sciences Corp C/Wts 07/11/2025、Morphosys涨幅较大，Biorestorative Therapies Inc、Revelation Biosciences Inc、Genprex Inc较为活跃，换手率分别为333.30%、107.60%、89.04%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Morphosys、Lexaria Bioscience Corp C/Wts 14/01/2026 ，振幅分别为310.53%、50.32%、48.31%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060126197a4184ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402060126197a4184ff&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408265663","title":"Tg Therapeutics Inc盘中异动 下午盘股价大涨5.05%报17.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2408265663","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408265663?lang=zh_cn&edition=full","pubTime":"2024-02-02 03:13","pubTimestamp":1706814836,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日03时13分，Tg Therapeutics Inc股票出现波动，股价急速拉升5.05%。截至发稿，该股报17.06美元/股，成交量220.89万股，换手率1.46%，振幅6.59%。Tg Therapeutics Inc股票所在的生物技术行业中，整体涨幅为1.10%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Neurobo Pharmaceuticals Inc、Gri Bio Inc涨幅较大，Gri Bio Inc、Neurobo Pharmaceuticals Inc、Revelation Biosciences Inc较为活跃，换手率分别为2802.37%、1249.44%、1048.00%，振幅较大的相关个股有Gri Bio Inc、Kiora Pharmaceuticals Inc、Neurobo Pharmaceuticals Inc，振幅分别为207.75%、69.32%、64.22%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020203135787e6b3d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020203135787e6b3d3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2408935325","title":"Tg Therapeutics Inc盘中异动 急速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408935325","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2408935325?lang=zh_cn&edition=full","pubTime":"2024-02-01 03:42","pubTimestamp":1706730145,"startTime":"0","endTime":"0","summary":"北京时间2024年02月01日03时42分，Tg Therapeutics Inc股票出现波动，股价大幅上涨5.01%。截至发稿，该股报16.98美元/股，成交量275.511万股，换手率1.82%，振幅7.17%。Tg Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，2Seventy Bio Inc、Kintara Therapeutics Inc、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Revelation Biosciences Inc、Ensysce Biosciences Inc、Kintara Therapeutics Inc较为活跃，换手率分别为837.38%、557.67%、506.35%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Psyence Biomedical Ltd、Neximmune Inc，振幅分别为90.24%、69.63%、66.53%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020103422687e6aa8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024020103422687e6aa8e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2403789854","title":"Tg Therapeutics Inc盘中异动 股价大跌5.07%报14.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2403789854","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2403789854?lang=zh_cn&edition=full","pubTime":"2024-01-16 22:44","pubTimestamp":1705416268,"startTime":"0","endTime":"0","summary":"北京时间2024年01月16日22时44分，Tg Therapeutics Inc股票出现波动，股价急速跳水5.07%。截至发稿，该股报14.97美元/股，成交量103.007万股，换手率0.68%，振幅3.23%。Tg Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Elevai Labs Inc、Celularity Inc C/Wts 16/07/2026 、Ys Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Elevai Labs Inc、Atreca Inc、Kintara Therapeutics Inc较为活跃，换手率分别为91.27%、10.90%、9.87%，振幅较大的相关个股有Moolec Science Sa C/Wts 、Elevai Labs Inc、Revolution Medicines Inc C/Wts  ，振幅分别为43.57%、40.94%、30.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401162244297a3ba2f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401162244297a3ba2f7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2403622452","title":"Tg Therapeutics Inc盘中异动 快速下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2403622452","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2403622452?lang=zh_cn&edition=full","pubTime":"2024-01-13 00:39","pubTimestamp":1705077559,"startTime":"0","endTime":"0","summary":"北京时间2024年01月13日00时39分，Tg Therapeutics Inc股票出现异动，股价快速下跌5.11%。截至发稿，该股报16.34美元/股，成交量217.68万股，换手率1.44%，振幅5.43%。Tg Therapeutics Inc股票所在的生物技术行业中，整体涨幅为0.91%。Tg Therapeutics Inc公司简介：TG Therapeutics Inc 是一家完全整合的商业阶段生物制药公司，专注于 B 细胞疾病新型疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401130039197a3ac460&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401130039197a3ac460&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2402102006","title":"Tg Therapeutics Inc盘中异动 早盘急速拉升6.59%报22.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2402102006","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2402102006?lang=zh_cn&edition=full","pubTime":"2024-01-10 22:31","pubTimestamp":1704897079,"startTime":"0","endTime":"0","summary":"北京时间2024年01月10日22时31分，Tg Therapeutics Inc股票出现异动，股价快速上涨6.59%。截至发稿，该股报22.39美元/股，成交量72.9279万股，换手率0.48%，振幅2.76%。Tg Therapeutics Inc股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Clearmind Medicine Inc、Effector Therapeutics Inc C/Wts 31/12/2025 、Exicure Inc涨幅较大，Clearmind Medicine Inc、Exicure Inc、Tc Biopharm  Plc较为活跃，换手率分别为1228.67%、64.45%、25.63%，振幅较大的相关个股有Clene Inc C/Wts 30/12/2025 、Clearmind Medicine Inc、安皮奥制药，振幅分别为37.90%、13.04%、8.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011022311987aa78d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024011022311987aa78d5&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tgtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0485},{"period":"1month","weight":0.1959},{"period":"3month","weight":0.2457},{"period":"6month","weight":0.3007},{"period":"1year","weight":-0.4497},{"period":"ytd","weight":-0.0351}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0705},{"period":"3month","weight":0.067},{"period":"6month","weight":0.1649},{"period":"1year","weight":0.2662},{"period":"ytd","weight":0.1152}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"TG Therapeutics, Inc.于1993年在特拉华州成立。该公司是一家完全整合、处于商业阶段的生物制药公司，专注于B细胞疾病新疗法的收购、开发和商业化。除了包括几种研究药物在内的一系列研究外，TG还获得了美国食品药品监督管理局（FDA）的BRIUMVI（ublituximab-xiiy）批准，用于治疗成人复发性多发性硬化症（RMS）患者，包括临床孤立综合征、复发缓解性疾病和活动性继发性进展性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.055658},{"month":2,"riseRate":0.727273,"avgChangeRate":0.087019},{"month":3,"riseRate":0.636364,"avgChangeRate":0.095138},{"month":4,"riseRate":0.363636,"avgChangeRate":0.008444},{"month":5,"riseRate":0.545455,"avgChangeRate":0.01821},{"month":6,"riseRate":0.454545,"avgChangeRate":0.054707},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.011011},{"month":8,"riseRate":0.545455,"avgChangeRate":-0.037575},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.059055},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.07532},{"month":11,"riseRate":0.909091,"avgChangeRate":0.172914},{"month":12,"riseRate":0.545455,"avgChangeRate":0.134525}],"exchange":"NASDAQ","name":"TG Therapeutics Inc.","nameEN":"TG Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"TG Therapeutics Inc.,TGTX,TG Therapeutics Inc.股票,TG Therapeutics Inc.股票老虎,TG Therapeutics Inc.股票老虎国际,TG Therapeutics Inc.行情,TG Therapeutics Inc.股票行情,TG Therapeutics Inc.股价,TG Therapeutics Inc.股市,TG Therapeutics Inc.股票价格,TG Therapeutics Inc.股票交易,TG Therapeutics Inc.股票购买,TG Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TG Therapeutics Inc.(TGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供TG Therapeutics Inc.(TGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}